Showing results (1501-1510 of 1,841) with videos related to
Sort By:
Pageof 185
Nature Communications|May 3, 2022
Indigenous oyster fisheries persisted for millennia and should inform future managementLeslie Reeder-Myers, Todd J Braje, Courtney A Hofman, et al.BMJ Open|June 18, 2025
Timely post-discharge medication reviews to Improve Continuity-the Transitions Of Care stewardship (TIC TOC) study in rural and regional Australia: a parallel-group randomised controlled trial study protocolJonathan Penm, Kingston Yeung, Rebekah Jane Moles, et al.Journal of Molecular and Cellular Cardiology|October 8, 2021
3D-cardiomics: A spatial transcriptional atlas of the mammalian heartMonika Mohenska, Nathalia M Tan, Alex Tokolyi, et al.Neuroimage|March 14, 2022
Good scientific practice in EEG and MEG research: Progress and perspectivesGuiomar Niso, Laurens R Krol, Etienne Combrisson, et al.Proceedings of the National Academy of Sciences of the United States of America|September 17, 2017
Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrestRichard J Mills, Drew M Titmarsh, Xaver Koenig, et al.Journal of Medicinal Chemistry|November 26, 2010
Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejectionMark E Flanagan, Todd A Blumenkopf, William H Brissette, et al.Leukemia & Lymphoma|March 12, 2020
Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysisRachel J Bubik, Dylan M Barth, Christopher Hook, et al.Blood|January 24, 2004
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control studyAngela Dispenzieri, Robert A Kyle, Martha Q Lacy, et al.Plos One|January 30, 2010
Risk of ovarian cancer and inherited variants in relapse-associated genesAbraham Peedicayil, Robert A Vierkant, Lynn C Hartmann, et al.Bone Marrow Transplantation|August 4, 2009
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinomaM R Litzow, P P Peethambaram, S L Safgren, et al.Pageof 185